{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T05:37:47Z","timestamp":1732340267956,"version":"3.28.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"DOI":"10.7759\/cureus.74246","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:51:15Z","timestamp":1732294275000},"source":"Crossref","is-referenced-by-count":0,"title":["Bullous Pemphigoid Induced by Cefixime: A Rare Side Effect"],"prefix":"10.7759","author":[{"given":"Nicolas","family":"Sandakly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgio","family":"El Koubayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Nassereddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin S","year":"2011","unstructured":"Bastuji-Garin S, Joly P, Lemordant P, et al.. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011, 131:637-43. 10.1038\/jid.2010.301","journal-title":"J Invest Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan SM","year":"2011","unstructured":"Langan SM, Groves RW, West J. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol. 2011, 131:631-6. 10.1038\/jid.2010.357","journal-title":"J Invest Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"Bastuji-Garin S","year":"1996","unstructured":"Bastuji-Garin S, Joly P, Picard-Dahan C, et al.. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol. 1996, 132:272-6. 10.1001\/archderm.1996.03890270044006","journal-title":"Arch Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: a UK case-control study","volume":"149","author":"Lloyd-Lavery A","year":"2013","unstructured":"Lloyd-Lavery A, Chi CC, Wojnarowska F, Taghipour K. The associations between bullous pemphigoid and drug use: a UK case-control study. JAMA Dermatol. 2013, 149:58-62. 10.1001\/2013.jamadermatol.376","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden MJ","year":"2020","unstructured":"Verheyden MJ, Bilgic A, Murrell DF. A systematic review of drug-induced pemphigoid. Acta Derm Venereol. 2020, 100:1-9. 10.2340\/00015555-3457","journal-title":"Acta Derm Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors","volume":"10","author":"Moro F","year":"2020","unstructured":"Moro F, Fania L, Sinagra JL, Salemme A, Di Zenzo G. Bullous pemphigoid: trigger and predisposing factors. Biomolecules. 2020, 10:1432. 10.3390\/biom10101432","journal-title":"Biomolecules"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000500","article-title":"Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature","volume":"28","author":"Zhao CY","year":"2018","unstructured":"Zhao CY, Hwang SJ, Consuegra G, Chou S, Fernandez-Pe\u00f1as P. Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature. Melanoma Res. 2018, 28:491-501. 10.1097\/CMR.0000000000000500","journal-title":"Melanoma Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2012.01636.x","article-title":"Case of drug-induced bullous pemphigoid by levofloxacin","volume":"39","author":"Ma HJ","year":"2012","unstructured":"Ma HJ, Hu R, Jia CY, Yang Y, Song LJ. Case of drug-induced bullous pemphigoid by levofloxacin. J Dermatol. 2012, 39:1086-7. 10.1111\/j.1346-8138.2012.01636.x","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000283","article-title":"Ciprofloxacin as a trigger for bullous pemphigoid: the second case in the literature","volume":"23","author":"Cozzani E","year":"2016","unstructured":"Cozzani E, Chinazzo C, Burlando M, Romagnoli M, Parodi A. Ciprofloxacin as a trigger for bullous pemphigoid: the second case in the literature. Am J Ther. 2016, 23:e1202-4. 10.1097\/MJT.0000000000000283","journal-title":"Am J Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1997.tb03302.x","article-title":"Bullous pemphigoid-like lesions induced by amoxicillin","volume":"36","author":"Miralles J","year":"1997","unstructured":"Miralles J, Barnadas MA, Baselga E, Gelp\u00ed C, Rodr\u00edguez JL, de Moragas JM. Bullous pemphigoid-like lesions induced by amoxicillin. Int J Dermatol. 1997, 36:42-7. 10.1111\/j.1365-4362.1997.tb03302.x","journal-title":"Int J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2001.00497.x","article-title":"Bullous pemphigoid induced by cephalexin","volume":"42","author":"Czechowicz RT","year":"2001","unstructured":"Czechowicz RT, Reid CM, Warren LJ, Weightman W, Whitehead FJ. Bullous pemphigoid induced by cephalexin. Australas J Dermatol. 2001, 42:132-5. 10.1046\/j.1440-0960.2001.00497.x","journal-title":"Australas J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1991.tb03867.x","article-title":"Pemphigus and bullous pemphigoid due to drugs","volume":"30","author":"Ruocco V","year":"1991","unstructured":"Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol. 1991, 30:307-12. 10.1111\/j.1365-4362.1991.tb03867.x","journal-title":"Int J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1984.01650450078023","article-title":"Bullous pemphigoid-like lesions induced by phenacetin. Report of a case and an immunopathologic study","volume":"120","author":"Kashihara M","year":"1984","unstructured":"Kashihara M, Danno K, Miyachi Y, Horiguchi Y, Imamura S. Bullous pemphigoid-like lesions induced by phenacetin. Report of a case and an immunopathologic study. Arch Dermatol. 1984, 120:1196-9. 10.1001\/archderm.1984.01650450078023","journal-title":"Arch Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.03839.x","article-title":"Medication history of a series of patients with bullous pemphigoid from northern Greece - observations and discussion","volume":"48","author":"Patsatsi A","year":"2009","unstructured":"Patsatsi A, Vyzantiadis TA, Chrysomallis F, Devliotou-Panagiotidou D, Sotiriadis D. Medication history of a series of patients with bullous pemphigoid from northern Greece - observations and discussion. Int J Dermatol. 2009, 48:132-5. 10.1111\/j.1365-4632.2009.03839.x","journal-title":"Int J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.731774","article-title":"Case report: a rare case of pembrolizumab-induced bullous pemphigoid","volume":"12","author":"Zhang X","year":"2021","unstructured":"Zhang X, Sui D, Wang D, Zhang L, Wang R. Case report: a rare case of pembrolizumab-induced bullous pemphigoid. Front Immunol. 2021, 12:731774. 10.3389\/fimmu.2021.731774","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319199-bullous-pemphigoid-induced-by-cefixime-a-rare-side-effect","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:51:18Z","timestamp":1732294278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319199-bullous-pemphigoid-induced-by-cefixime-a-rare-side-effect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.74246","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,22]]}}}